TickerFacts.

Caris Life Sciences, Inc. (CAI): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$3.22
Year ended 2025-12-31
2023-12-31: -$13.242024-12-31: -$10.662025-12-31: -$3.22-$3.22
2023-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$3.22n/m2026-03-03, From 2025-01-01
2024-12-31-$10.66n/m2026-03-03, From 2024-01-01
2023-12-31-$13.24n/a2026-03-03, From 2023-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Caris Life Sciences, Inc. (CAI)2025-12-31-$3.22n/m
Guardant Health, Inc. (GH)2025-12-31-$3.32n/m
Veracyte, Inc. (VCYT)2025-12-31$0.82+164.5%
CareDx, Inc. (CDNA)2025-12-31-$0.40n/m
Castle Biosciences Inc (CSTL)2025-12-31-$0.83n/m
RadNet, Inc. (RDNT)2025-12-31-$0.25n/m
BillionToOne, Inc. (BLLN)2025-12-31$0.14n/m
Natera, Inc. (NTRA)2025-12-31-$1.52n/m
Fortrea Holdings Inc. (FTRE)2025-12-31-$10.81n/m

Compare CAI, GH, VCYT, CDNA side by side · Screen every company in Services-Medical Laboratories ↗